Patientory

Empowering patients through data management and increasing patient satisfaction for organizations, Patientory harnesses predictive analytics to improve patient and population health outcomes and provides encrypted blockchain storage. Patientory combines the power of rapid and secure medical record access with a patient community platform.

Our increased interoperability improves care coordination while ensuring data security, minimizing health breaches with an 85% decrease in hospital readmissions and penalties and yielding a 42% decrease in IT expenditures.

Chronic diseases account for over 60% of deaths globally. 

Patientory is focusing on launching in the United States first before expanding globally. There are currently 153 million chronically ill Americans, and of this, 60% are adults and 40% have two or more chronic conditions. Patients and providers still face challenges managing health data on a daily basis, as healthcare is generalized, not personalized, and data aggregation is limited. Both providers and patients lack the comprehensive data to make the most efficient decisions, as 66% of US citizens have concerns when health data is managed electronically and 75% of hospitals experience inefficiencies in cost and management due to complexity of care. Electronic medical records are not integrated seamlessly across providers and lifestyle data/SDOH is not a component of care plan creation, leading to rising healthcare costs and poor health outcomes. 

Providers cannot see the bigger picture due to the lack of interoperability and access across current management systems; they cannot create efficient care plans for patients without access to all patient data. This lack of access, interoperability, and personalization has resulted in an increase in chronic illnesses, data breaches, and fines, and a decrease in patient satisfaction and quality of care.

Patientory democratizes individual ownership of the world’s health data and incentives to improve health outcomes. 

Specifically, Patientory Inc. is a population health data management and analytics company. Through its two decentralized applications, the Patientory mobile app and enterprise software tool Neith, Patientory Inc. provides patients (B2C) with access and insights and enterprises (B2B) with comprehensive healthcare data, risk management analytics, and AI- driven clinical trial recruitment management systems to improve population health outcomes and employ personalized care plans that consider the entire history of the patient, including the social determinants of health. This is achieved by integrating a blockchain enabled network to gather and analyze siloed healthcare data, which includes daily lifestyle factors, and in turn, reduce the cost of care.

Our increased interoperability improves care coordination while ensuring data security, minimizing health breaches and penalties and decreasing IT expenditures. When used together, both platforms work synergistically to improve the quality of care plans and reduce the cost of care. 

We utilize a B2B2C SaaS subscription model.  

For enterprise, we target companies engaged in clinical trials (for patient recruitment, monitoring), as well as organizations involved in insurance, employers, and healthcare providers. For our enterprise customers, our secure interoperability improves care coordination and the ability to mine large healthcare data sets. Through machine learning (specifically, predictive analytics) and the PTOYMatrix blockchain-enabled interoperability network, our solutions break down silos to improve workflows and care coordination for the entirety of the healthcare ecosystem. 

Our synergistic consumer app solution tackles enterprise issues as well. The patient/consumer is able to see their electronic medical records, lifestyle data from wearable devices, and social determinants of health data on one platform. Patients are able to track and improve their health via predictive analytics, gamification/incentives, and a health score. Increasing patient satisfaction improves outcomes and reduces costs for enterprise. 

We engage our potential customers in surveys, questionnaires, and case studies to ensure that our solutions target their specific pain points. 

Enterprises can manage and identify high risk patients who are prone to develop a chronic ailment. Patientory provides enterprises (B2B) with comprehensive healthcare data, risk management analytics based on genomic medical and healthcare information, and AI- driven clinical trial recruitment management systems to improve population health outcomes and employ personalized care plans that consider the entire history of the patient. 

Our solutions have added COVID-19 tracking abilities to identify if a patient is at risk or is traveling to an area in which they would be at risk. Within our application, we provide incentives for patients/consumers via a health score. 

Patientory is set to grow and launch its solutions at the end of Q2, 2021. We have over 45,000+ subscribers globally interested in our solution. By 2020, we gained 17+ strategic partnerships, including Startup Health, Trialscope, which facilitated Patientory’s patient recruitment for Moderna and Novavax vaccine trials, and the Georgia Department of Economic Development/Metro Atlanta Chamber. We have access to 90% of the US’s health data due to our 10,000 health system integration with 1UpHealth. 

Our KPIs that paint the picture of our impact are: 45,000+ subscriber count , 10,000+ hospital patient and data access, 17+ partners, 6+ active clinical trials including Moderna COVID-19. 

We measure the amount of healthcare organizations being added to the PTOYMatrix healthcare ecosystem, and thus, measure the furthered interoperability of care globally. On the consumer side, we measure # clinical trial enrollees and app downloads to understand how our solution is valuable to patients. 

Patientory has 5 patents, 20 pending patents. Specifically, Patientory uses: 

Patientory’s Predictive Analytics - 1. Data storage from multiple providers and encounters using blockchain (distributed ledger technology (after consent from patients and smart contract creation)) 2. aggregating data such as registries, utilization, trends, outlier detection and alerts, and impact assessment 3. Using an AI/ML layer to determine efficient and holistic care personalized to each individual (through Patientory’s consumer app (B2C) and enterprise (B2B) solutions) 

Patientory is one of the first companies using Blockchain technology in the Health IT market, and provides a solution for both patients and providers. Our products are built on the PTOYMatrix network, a HIPAA-compliant blockchain enabled Health Information Exchange & Storage network, administered by the Patientory Association, which facilitates the secure and encrypted storage and exchange of private health information.

We can integrate into the major EHR systems: Epic, Cerner, Allscripts, Meditech, and Athenahealth with AI services to provide better insight. Our company utilizes advanced analytics and machine learning from real-time patient-generated data captured from our application to provide predictive, personalized, and prescriptive recommendations for patient care and healthcare cost reduction.

We are currently pre-launch; however, our KPIs that paint the picture of our impact are: 45,000+ subscriber count (patients and individuals interested in our consumer app), 10,000+ hospital (academic and community) patient and data access which represents 90% of US healthcare data, 17+ partners, 6+ active clinical trials including Moderna COVID-19.

# app downloads/month, # app downloads/day, # strategic partnerships, amount of hospital data access, # community hospital partnerships that include data access, # healthcare organizations in the PTOYMatrix, # publications/thought leadership/public scholarship for available use to improve health outcomes, # clinical trial recruitments

4 team members

• Chrissa McFarlane (CEO), Patientory, Patientory Association 

• Xueling Wang (Business Development Analyst), Patientory, Patientory Association, Georgia State

• Thileepan Sivanandham (Technical Lead), Patientory, Patientory Association, Maax Market 

• Ankita Moss (Product Marketing Associate), Patientory, Patientory Association, Emory University Center for Ethics

Our team has diverse experiences in business, serial startup founding, and clinical/biomedical research. We have the unique holistic experience to successfully launch Patientory. 

• Chrissa McFarlane (CEO) founded the company after seeing the need for more personalized and secure consumer driven health information systems. She has more than 10 years experience in healthcare technology. Chrissa holds an MA in Business Management from Wake Forest University and BA from Cornell University. 

• Xueling Wang (Business Development Analyst): Xueling holds a BA in Health Information and Medical Records Administration from Georgia State University. 

• Thileepan Sivanandham (Technical Lead): He has over 11 years experience in software development and starting companies. 

• Ankita Moss (Product Marketing Associate): Ankita holds a BS in Neuroscience from Emory University. 

• IP: 5 issued patents, 20 patents pending

Patientory is an equal opportunity employer and considers all qualified applicants equally without regard to race, color, religion, sex, sexual orientation, gender identity, or national origin.

Patientory is tackling siloed data management and incomplete information through predictive analytics and a blockchain-enabled health information network. Our solutions are built on the global blockchain-enabled PTOYMatrix and work synergistically upon this infrastructure. This harmony is what drives our solutions' value propositions to break silos, enhance interoperability, and in turn, improve health outcomes across global populations.  However, healthcare is a sector that is traditionally slow to adopt new technologies. Predictive analytics, blockchain, and digital health are all new innovative technologies to the healthcare sector. So far, we have built a robust network of partnerships across healthcare providers, clinical trials/pharma, and insurance/employer organizations. We have harnessed corporate partnerships to build our pitch and use case. Partnerships have been key to our marketing, launch, and growth plans, as we must build trust and educate our consumer as we pitch our solution that relies on these new technologies. The Trinity Challenge tackles the exact problem we are aiming to solve and offers partnership opportunities as well as funding. We see the partnership opportunities within the Trinity Challenge as the next step in our growth plan.  Furthermore, Patientory launches Q2/2021. Funding will be integral to a successful sales strategy.

We have raised more than 1.5 million so far and are now seeking to close our pre-seed round of investment to continue perfecting Patientory products and developing more features to better serve our customers and bring positive impacts into people’s lives.The proceeds will demonstrate the value of our solution and determine our next step in product development. 

Palantir- Partnership to offer our decentralized blockchain solution for healthcare data storage transmission and access

Aviva/Optum- Data Insights and Insurance risk mitigation for members

Bill and Melinda Gates Foundation- providing research and prevention plans for international expansion

GSK- ability to utilize platforms for clinical trial recruitment

Google, Facebook, McKinsey- providing research and employee wellness pilots

Patientory is tackling siloed data management and incomplete information through predictive analytics and a blockchain-enabled health information network. Our solutions are built on the global blockchain-enabled PTOYMatrix and work synergistically upon this infrastructure. This harmony is what drives our solutions' value propositions to break silos, enhance interoperability, and in turn, improve health outcomes across global populations. 

However, healthcare is a sector that is traditionally slow to adopt new technologies. Predictive analytics, blockchain, and digital health are all new innovative technologies to the healthcare sector. So far, we have built a robust network of partnerships across healthcare providers, clinical trials/pharma, and insurance/employer organizations. We have harnessed corporate partnerships to build our pitch and use case. Partnerships have been key to our marketing, launch, and growth plans, as we must build trust and educate our consumer as we pitch our solution that relies on these new technologies. The Robert Wood Johnson Foundation prize the exact problem we are aiming to solve and offers partnership opportunities as well as funding. We see the partnership opportunities within the Robert Wood Johnson Foundation prize as the next step in our growth plan. 
Furthermore, Patientory launches Q2/2021. Funding will be integral to a successful sales strategy.

The use of proceeds: 40% New Hires, 30% Marketing, 18% Operational Cost, 12% Product Development. 

Patientory Inc. and UK-based IrisGuard collaboration to combine leading iris biometric technology and healthcare focused PTOYNet blockchain network for enhanced security measures. 

In 2013, irisguard help the UNHCR to irisenable their registration process of refugees.All Syrian refugees have their irises registered using irisguard technology in a database that is owned and managed by the UNHCR. Irisguard has further supported refugees through a system that allows payment for supermarket groceries at the cash register with an irisenabled system linked to the POS. Iris scans replace cash and coupons in Jordanian refugee camps because the system authenticates identity and completes the transaction in the same way as if they had a card.

Patientory, Inc., a startup making waves in healthcare, will help to reduce drug-abuse through pharmaceutical fraud with iris-recognition (eye-scanning) technology. Using the breakthrough technology that was approved by the United Nations to verify the identities of over 2.3 million refugees, Patientory is bringing UK-based IrisGuard’s revolutionary technology to the U.S.. By replacing the typical patient and ID authentication methods with an iris, providers will be able to quickly and accurately confirm an individual’s identity. Patientory, Inc. will roll out this application in pharmaceutical clinical trials.

The Andan Prize for Innovation in Refugee inclusion the exact problem we are aiming to solve and offers partnership opportunities as well as funding.  

Furthermore, Patientory launches Q2/2021. Funding will be integral to a successful sales strategy.The use of proceeds: 40% New Hires, 30% Marketing, 18% Operational Cost, 12% Product Development. 

Patientory provides enterprises (B2B) with comprehensive healthcare data, risk management analytics based on genomic medical and healthcare information, and AI- driven clinical trial recruitment management systems to improve population health outcomes and employ personalized care plans that consider the entire history of the patient, including the social determinants of health. This is achieved by integrating a blockchain enabled network to gather and analyze siloed healthcare data. Data is accumulated in realtime through our B2C platform that gives patients ownership and access to their data.
Patientory improves population health outcomes and creates more accurate at-risk identifiers. Our solutions have added COVID-19 tracking abilities to identify if a patient is at risk or is traveling to an area in which they would be at risk. Furthermore, within our application, we provide incentives for patients/consumers via a health score. Users can earn PTOY (our cryptocurrency) for completing and going beyond their recommended care plans and/or adhering to back-to-work initiatives within our employer partnerships.

Our CEO/Founder Chrissa McFarlance was named as one of the top women,“leaving their mark on the MedTech field in health IT,” by Becker’s Hospital Review. 

The use of proceeds: 40% New Hires, 30% Marketing, 18% Operational Cost, 12% Product Development. 

Patientory provides enterprises (B2B) with comprehensive healthcare data, risk management analytics based on genomic medical and healthcare information, and AI- driven clinical trial recruitment management systems to improve population health outcomes and employ personalized care plans that consider the entire history of the patient, including the social determinants of health. This is achieved by integrating a blockchain enabled network to gather and analyze siloed healthcare data. Data is accumulated in realtime through our B2C platform that gives patients ownership and access to their data.
Patientory improves population health outcomes and creates more accurate at-risk identifiers. Our solutions have added COVID-19 tracking abilities to identify if a patient is at risk or is traveling to an area in which they would be at risk. Furthermore, within our application, we provide incentives for patients/consumers via a health score. Users can earn PTOY (our cryptocurrency) for completing and going beyond their recommended care plans and/or adhering to back-to-work initiatives within our employer partnerships. 

The use of proceeds: 40% New Hires, 30% Marketing, 18% Operational Cost, 12% Product Development.